tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Novartis sees +5%-6% sales CAGR cc for 2025-2030
PremiumThe FlyNovartis sees +5%-6% sales CAGR cc for 2025-2030
8d ago
Novartis AG: Hold Rating Amid Moderate Growth and Valuation Concerns
Premium
Ratings
Novartis AG: Hold Rating Amid Moderate Growth and Valuation Concerns
9d ago
Novartis to build manufacturing hub in North Carolina
Premium
The Fly
Novartis to build manufacturing hub in North Carolina
9d ago
Cautious Hold on Novartis AG Amid Mixed Ianalumab Data and Valuation Concerns
PremiumRatingsCautious Hold on Novartis AG Amid Mixed Ianalumab Data and Valuation Concerns
25d ago
Novartis upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Novartis upgraded to Overweight from Equal Weight at Morgan Stanley
29d ago
Positive Long-Term Growth Outlook for Novartis AG Amid Temporary Setbacks
Premium
Ratings
Positive Long-Term Growth Outlook for Novartis AG Amid Temporary Setbacks
29d ago
Novartis announces expiration of Tourmaline Bio tender offer
PremiumThe FlyNovartis announces expiration of Tourmaline Bio tender offer
1M ago
Novartis price target raised to CHF 108 from CHF 105 at Morgan Stanley
Premium
The Fly
Novartis price target raised to CHF 108 from CHF 105 at Morgan Stanley
1M ago
Midday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations
Premium
The Fly
Midday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100